InnerOptic has announced it has received FDA clearance for its AIM system, according to a news release (pdf).
AIM received clearance for guiding an interventional needle and for predicting its future path on a stereoscopic monitor. The company describes AIM as a "GPS" for needle-based interventions. It provides 3D visualization and guidance for ultrasound-assisted open, percutaneous and laparoscopic biopsies and ablations, according to the release.
AIM has been successfully integrated with ultrasound scanners from BK Medical and Aloka, and devices from Halt Medical and Microsulis.
InnerOptic is headquartered in Hillsborough, N.C.
Related Articles on FDA Clearances:
Cardinal Health Receives Additional FDA Clearances for Durablue Sterilization Wrap
Aptus Endosystems Receives FDA Clearance for Aortic Securement System
Access Scientific Receives FDA Clearance for Peripheral IV Catheter